For more information or confidential assistance
Call 800-306-3180

AACE Plans Meeting to Examine SGLT2 Inhibitor Side Effects

diabetes
In late June, the American Association of Clinical Endocrinologists announced plans for a conference where U.S. and international experts will examine whether SGLT2 inhibitor side effects include diabetic ketoacidosis. Organizers hope the meeting will provide answers to questions from AACE members regarding recent reports and... Read More

Manufacturer Wants Zofran Lawsuits Centralized

zofran bottle
GlaxoSmithKline (GSK), the manufacturer of an anti-nausea drug at the center of controversy over the harm it allegedly causes developing fetuses, has filed a motion to centralize all Zofran lawsuits alleging birth defects before one judge. The manufacturer has petitioned for the establishment of a federal... Read More